Stephen V Liu: Stereotactic radiation for treatment of brain metastases in SCLC
Stephen V Liu, Chief of Division of Hematology and Oncology at Georgetown Lombardi Comprehensive Cancer Center, shared on X:
“Prospective study of stereotactic radiation for treatment of brain metastases (1-10) in SCLC (instead of whole brain radiation) Journal of Clinical Oncology. In 100 patients (median number of metastases was 2), only 22% of pts required salvage WBRT, mOS 10.2m.”
Title: Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial
Authors: Ayal A. Aizer, Shyam K. Tanguturi, Diana D. Shi, Paul J. Catalano, Kee-Young Shin, Ivy Ricca, Marciana Johnson, Grant Benham, David E. Kozono, Raymond H. Mak, Lauren Hertan, Fallon Chipidza, Monica Krishnan, Itai Pashtan, Luke Peng, Jack M. Qian, Ron Y. Shiloh, Daniel N. Cagney, Jacob Sands, Paul D. Brown, Patrick Y. Wen, Daphne A. Haas-Kogan, Rifaquat Rahman
Read the Full Article on Journal of Clinical Oncology.
More posts featuring Stephen V Liu.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023